237 related articles for article (PubMed ID: 22292446)
1. Drug treatment of obesity in cardiovascular disease.
Charakida M; Finer N
Am J Cardiovasc Drugs; 2012 Apr; 12(2):93-104. PubMed ID: 22292446
[TBL] [Abstract][Full Text] [Related]
2. Obesity: new perspectives and pharmacotherapies.
Palamara KL; Mogul HR; Peterson SJ; Frishman WH
Cardiol Rev; 2006; 14(5):238-58. PubMed ID: 16924165
[TBL] [Abstract][Full Text] [Related]
3. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
[TBL] [Abstract][Full Text] [Related]
4. Medications for weight reduction.
Bray GA
Endocrinol Metab Clin North Am; 2008 Dec; 37(4):923-42. PubMed ID: 19026940
[TBL] [Abstract][Full Text] [Related]
5. Adherence to weight loss medications; post-marketing study from HMO pharmacy data of one million individuals.
Hemo B; Endevelt R; Porath A; Stampfer MJ; Shai I
Diabetes Res Clin Pract; 2011 Nov; 94(2):269-75. PubMed ID: 21907442
[TBL] [Abstract][Full Text] [Related]
6. The new role of pharmacotherapy for weight reduction in obesity.
Fernstrom MH; Fernstrom JD
Int J Clin Pract; 2002 Nov; 56(9):683-6. PubMed ID: 12469983
[TBL] [Abstract][Full Text] [Related]
7. Drug therapy for obesity.
Dickerson LM; Carek PJ
Am Fam Physician; 2000 Apr; 61(7):2131-8, 2143. PubMed ID: 10779254
[TBL] [Abstract][Full Text] [Related]
8. New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.
Scheen AJ; Ernest P
Diabetes Metab; 2002 Dec; 28(6 Pt 1):437-45. PubMed ID: 12522323
[TBL] [Abstract][Full Text] [Related]
9. Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study.
Richelsen B; Tonstad S; Rössner S; Toubro S; Niskanen L; Madsbad S; Mustajoki P; Rissanen A
Diabetes Care; 2007 Jan; 30(1):27-32. PubMed ID: 17192328
[TBL] [Abstract][Full Text] [Related]
10. Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options.
Fujioka K
Obes Res; 2002 Dec; 10 Suppl 2():116S-123S. PubMed ID: 12490660
[TBL] [Abstract][Full Text] [Related]
11. Do we need anti-obesity drugs?
Hainer V; Hainerová IA
Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():8-20. PubMed ID: 23280861
[TBL] [Abstract][Full Text] [Related]
12. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
Derosa G; Cicero AF; Murdolo G; Ciccarelli L; Fogari R
Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
[TBL] [Abstract][Full Text] [Related]
13. Effect of orlistat on cardiovascular disease risk in obese adults.
Swinburn BA; Carey D; Hills AP; Hooper M; Marks S; Proietto J; Strauss BJ; Sullivan D; Welborn TA; Caterson ID
Diabetes Obes Metab; 2005 May; 7(3):254-62. PubMed ID: 15811142
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of weight loss drugs on obesity and cardiovascular risk factors in obese adolescents: a meta-analysis of randomized controlled trials.
Czernichow S; Lee CM; Barzi F; Greenfield JR; Baur LA; Chalmers J; Woodward M; Huxley RR
Obes Rev; 2010 Feb; 11(2):150-8. PubMed ID: 19573052
[TBL] [Abstract][Full Text] [Related]
15. Why do we need drugs to treat the patient with obesity?
Bray GA
Obesity (Silver Spring); 2013 May; 21(5):893-9. PubMed ID: 23520198
[TBL] [Abstract][Full Text] [Related]
16. Anti-obesity drugs: a review about their effects and their safety.
Derosa G; Maffioli P
Expert Opin Drug Saf; 2012 May; 11(3):459-71. PubMed ID: 22439841
[TBL] [Abstract][Full Text] [Related]
17. Recent concepts of pharmacotherapy and bariatric surgery for childhood obesity: an overview.
Gogakos A; Tzotzas TC; Krassas GE
Pediatr Endocrinol Rev; 2009 Dec; 7(2):3-14. PubMed ID: 20118889
[TBL] [Abstract][Full Text] [Related]
18. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.
Lee M; Aronne LJ
Am J Cardiol; 2007 Feb; 99(4A):68B-79B. PubMed ID: 17307059
[TBL] [Abstract][Full Text] [Related]
19. [A practicing physician's view on obesity].
Juhász A; Katona E; Csongrádi E; Paragh G
Orv Hetil; 2006 Apr; 147(13):579-90. PubMed ID: 16623440
[TBL] [Abstract][Full Text] [Related]
20. Well-being of obese individuals: therapeutic perspectives.
Chaput JP; Tremblay A
Future Med Chem; 2010 Dec; 2(12):1729-33. PubMed ID: 21428796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
